The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions

被引:141
|
作者
Fehr, Anthony R. [1 ]
Singh, Sasha A. [2 ]
Kerr, Catherine M. [1 ]
Mukai, Shin [2 ]
Higashi, Hideyuki [2 ]
Aikawa, Masanori [2 ,3 ,4 ]
机构
[1] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[2] Harvard Med Sch, Ctr Interdisciplinary Cardiovasc Sci, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA
[3] Harvard Med Sch, Ctr Excellence Vasc Biol, Brigham & Womens Hosp, Boston, MA 02115 USA
[4] IM Sechenov First Moscow State Med Univ, Dept Human Pathol, Minist Hlth, Moscow 119146, Russia
基金
美国国家卫生研究院;
关键词
ADP-ribosylation; PARP; atherosclerosis; host-pathogen interactions; immunity; inflammation; macrophage; vascular disease; FINGER ANTIVIRAL PROTEIN; POLY(ADP-RIBOSE) POLYMERASE 1; AGGRESSIVE LYMPHOMA FAMILY; STRAND RNA VIRUSES; B-CELL LYMPHOMAS; RIBOSE POLYMERASE; MACROPHAGE ACTIVATION; NUCLEOCAPSID PROTEIN; WIDE IDENTIFICATION; VIRAL REPLICATION;
D O I
10.1101/gad.334425.119
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Poly-adenosine diphosphate-ribose polymerases (PARPs) promote ADP-ribosylation, a highly conserved, fundamental posttranslational modification (PTM). PARP catalytic domains transfer the ADP-ribose moiety from NAD(+) to amino acid residues of target proteins, leading to monoor poly-ADP-ribosylation (MARylation or PARylation). This PTM regulates various key biological and pathological processes. In this review, we focus on the roles of the PARP family members in inflammation and host-pathogen interactions. Here we give an overview the current understanding of the mechanisms by which PARPs promote or suppress proinflammatory activation of macrophages, and various roles PARPs play in virus infections. We also demonstrate how innovative technologies, such as proteomics and systems biology, help to advance this research field and describe unanswered questions.
引用
收藏
页码:341 / 359
页数:19
相关论文
共 50 条
  • [1] ADP-ribosylation and host-pathogen interactions
    Adams-Phillips, L.
    [J]. PHYTOPATHOLOGY, 2008, 98 (06) : S195 - S195
  • [2] PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages
    Santinelli-Pestana, Diego V.
    Aikawa, Elena
    Singh, Sasha A.
    Aikawa, Masanori
    [J]. PATHOGENS, 2023, 12 (07):
  • [3] Chemical reporters for exploring ADP-ribosylation and AMPylation at the host-pathogen interface
    Westcott, Nathan P.
    Hang, Howard C.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2014, 23 : 56 - 62
  • [4] PARPs and ADP-Ribosylation Come Into Focus
    Kraus, W. Lee
    [J]. MOLECULAR CELL, 2015, 58 (06) : 901 - 901
  • [5] PARPs and ADP-ribosylation: 60 years on
    Kraus, W. Lee
    [J]. GENES & DEVELOPMENT, 2020, 34 (5-6) : 251 - 253
  • [6] PARPs and ADP-Ribosylation: 50 Years ... and Counting
    Kraus, W. Lee
    [J]. MOLECULAR CELL, 2015, 58 (06) : 902 - 910
  • [7] PARPs and ADP-ribosylation Deciphering the complexity with molecular tools
    Dasovich, Morgan
    Leung, Anthony K. L.
    [J]. MOLECULAR CELL, 2023, 83 (10) : 1552 - 1572
  • [8] A new facet of ADP-ribosylation reactions: SIRTs and PARPs interplay
    Mennella, Maria Rosaria Faraone
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2015, 20 : 458 - 473
  • [9] Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity
    Brady, Pamlea N.
    Goel, Anupam
    Johnson, Margaret A.
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2019, 83 (01)
  • [10] PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
    Gupte, Rebecca
    Liu, Ziying
    Kraus, W. Lee
    [J]. GENES & DEVELOPMENT, 2017, 31 (02) : 101 - 126